Skip to main content
SpringerLink
Log in

What is the True Clinical Significance of Plasma Protein Binding Displacement Interactions?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sellers EM. Plasma protein displacement interactions are rarely of clinical significance. Pharmacology 1979; 18: 225–7

    Article  PubMed  CAS  Google Scholar 

  2. Rowland M, Tozer T. Clinical pharmacokinetics. Concepts and applications. 2nd ed. Philadelphia: Lea & Febiger, 1989: 255–75

    Google Scholar 

  3. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. 4th ed. Philadelphia: Lea & Febiger, 1991: 305–43

    Google Scholar 

  4. Svensson CK, Woodruff MN, Lalka D. Influence of protein binding and use of unbound (free) drug concentrations. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics. Principles of therapeutic drug monitoring. 2nd ed. Washington: Applied Therapeutics Inc, 1986: 187–219

    Google Scholar 

  5. Stockley IH. Drug interactions: a source book of adverse interactions, their mechanisms, clinical importance and management. Oxford: Blackwell Scientific, 1981

    Google Scholar 

  6. Hansten PD. Drug interactions: clinical significance of drug interactions. Philadelphia: Lea & Febiger, 1985

    Google Scholar 

  7. Prescott LF. Clinically important drug interactions. In: Avery GS, editor. Drug treatment. 3rd ed. Auckland: Adis Press, 1987: 255–82

    Google Scholar 

  8. MacKichan JJ. Protein binding displacement interactions. Fact or fiction? Clin Pharmacokinet 1989; 16: 65–73

    Article  PubMed  CAS  Google Scholar 

  9. du Souich P, Verges J, Erill S. Plasma protein binding and pharmacological response. Clin Pharmacokinet 1993; 24: 435–40

    Article  PubMed  Google Scholar 

  10. Rolan PE. Plasma protein binding displacement interactions — why are they still regarded as clinically important? Br J Clin Pharmacol 1994; 37: 125–8

    Article  PubMed  CAS  Google Scholar 

  11. Lima JJ. Disopyramide. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics. Principles of therapeutic drug monitoring. 2nd ed. Washington: Applied Therapeutics Inc., 1986: 1210–53

    Google Scholar 

  12. Jack DB. Handbook of clinical pharmacokinetic data. Basingstoke: Macmillan Publishers Ltd, 1992: 1–132

    Google Scholar 

  13. Miners JO. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. Clin Pharmacokinet 1989; 17: 327–44

    Article  PubMed  CAS  Google Scholar 

  14. Seller EM, Koch-Weser J. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. N Engl J Med 1970; 283: 827–31

    Article  Google Scholar 

  15. Udal JA. Warfarin-chloral hydrate interaction. Pharmacological activity and clinical significance. Ann Intern Med 1974; 81: 341–4

    Google Scholar 

  16. Aarons LJ, Rowland M. Kinetics of drug displacement interactions. J Pharmacokinet Biopharm 1981; 9: 181–90

    PubMed  CAS  Google Scholar 

  17. Wilkinson GR. Clearance. Pharmacol Rev 1987; 39: 1–47

    PubMed  CAS  Google Scholar 

  18. Morgan DJ, Smallwood RA. Clinical significance of pharmacokinetic models of hepatic elimination. Clin Pharmacokinet 1990; 18: 61–76

    Article  PubMed  CAS  Google Scholar 

  19. Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (part I). Clin Pharmacokinet 1990; 18: 37–60

    Article  PubMed  CAS  Google Scholar 

  20. Dahlqvist R, Borga O, Rane A, et al. Decreased plasma protein binding of phenytoin in patients on valproic acid. Br J Clin Pharmacol 1979; 8: 547–52

    Article  PubMed  CAS  Google Scholar 

  21. Monks A, Richens A. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients. Clin Pharmacol Ther 1980; 27: 89–95

    Article  PubMed  CAS  Google Scholar 

  22. Monks A, Boobis S, Wadsworth J, et al. Plasma protein binding interaction between phenytoin and valproic acid in vitro. Br J Clin Pharmacol 1978; 6: 487–92

    Article  PubMed  CAS  Google Scholar 

  23. Serlin MJ, Mossman S, Sibeon RG, et al. Interaction between diflunisal and warfarin. Clin Pharmacol Ther 1980; 28: 493–8

    Article  PubMed  CAS  Google Scholar 

  24. Freedman MD, Olatidoye AG. Clinically significant drug interactions with the oral anticoagulants. Drug Saf 1994; 10: 381–94

    Article  PubMed  CAS  Google Scholar 

  25. Lozada A, Dujovne CA. Drug interactions with fibric acids. Pharmacol Ther 1994; 63: 163–76

    Article  PubMed  CAS  Google Scholar 

  26. O’Reilly RA, Trager WF, Motley CH. Stereoselective interaction of phenylbutazone with (12C/13C) warfarin pseudoracemates in man. J Clin Invest 1980; 65: 746–53

    Article  PubMed  Google Scholar 

  27. Schary WL, Lewis RJ, Rowland M. Warfarin-phenylbutazone interaction in man: a long term multiple-dose study. Res Commun Chem Pathol Pharmacol 1975; 10: 663–72

    PubMed  CAS  Google Scholar 

  28. Bjornsson TD, Meffin PJ, Swezey S, et al. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction. J Pharmacol Exp Ther 1979; 210: 316–21

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy and Medical Sciences, University of South Australia, North Terrace, Adelaide, South Australia, 5000, Australia

    Lloyd N. Sansom & Allan M. Evans

Authors
  1. Lloyd N. Sansom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allan M. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sansom, L.N., Evans, A.M. What is the True Clinical Significance of Plasma Protein Binding Displacement Interactions?. Drug-Safety 12, 227–233 (1995). https://doi.org/10.2165/00002018-199512040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199512040-00001

Keywords

Search

Navigation